Home  |  Contact

Cellosaurus 1363-mel (CVCL_8042)

[Text version]
Cell line name 1363-mel
Synonyms 1363-MEL; 1363 mel; 1363
Accession CVCL_8042
Resource Identification Initiative To cite this cell line use: 1363-mel (RRID:CVCL_8042)
Comments From: Rosenberg S.A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
Derived from site: Metastatic; Not specified.
HLA typing Source: PubMed=10048982
Class I
HLA-AA*01,02
Disease Melanoma (NCIt: C3224)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Originate from same individual CVCL_WY45 ! 1363-EBV
Sex of cell Sex unspecified
Age at sampling Age unspecified
Category Cancer cell line
Publications

PubMed=10048982; DOI=10.1002/(SICI)1097-0215(19990301)80:5<781::AID-IJC24>3.0.CO;2-A
Cormier J.N., Panelli M.C., Hackett J.A., Bettinotti M.P., Mixon A., Wunderlich J.R., Parker L.L., Restifo N.P., Ferrone S., Marincola F.M.
Natural variation of the expression of HLA and endogenous antigen modulates CTL recognition in an in vitro melanoma model.
Int. J. Cancer 80:781-790(1999)

PubMed=19581576; DOI=10.1073/pnas.0903852106
Depontieu F.R., Qian J., Zarling A.L., McMiller T.L., Salay T.M., Norris A., English A.M., Shabanowitz J., Engelhard V.H., Hunt D.F., Topalian S.L.
Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapy.
Proc. Natl. Acad. Sci. U.S.A. 106:12073-12078(2009)

Cross-references
Encyclopedic resources Wikidata; Q54581660
Polymorphism and mutation databases Cosmic; 876704
Entry history
Entry creation04-Apr-2012
Last entry update29-Jun-2023
Version number13